These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14506022)

  • 1. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
    Curtin J; Cormican M; Fleming G; Keelehan J; Colleran E
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3145-8. PubMed ID: 14506022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
    Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
    J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G; Saba V
    JPEN J Parenter Enteral Nutr; 2007; 31(6):463-8. PubMed ID: 17947600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):655-9. PubMed ID: 23642281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs.
    Reiter KC; Villa B; Paim TGDS; de Oliveira CF; d'Azevedo PA
    J Med Microbiol; 2013 Mar; 62(Pt 3):394-399. PubMed ID: 23161766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms].
    Rodríguez-Martínez JM; Ballesta S; García I; Conejo MC; Pascual A
    Enferm Infecc Microbiol Clin; 2007; 25(7):425-8. PubMed ID: 17692209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm.
    Percival SL; Kite P; Eastwood K; Murga R; Carr J; Arduino MJ; Donlan RM
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):515-9. PubMed ID: 16018425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Curr Microbiol; 2011 Sep; 63(3):313-7. PubMed ID: 21761219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms.
    Reiter KC; Sant'Anna FH; d'Azevedo PA
    Int J Antimicrob Agents; 2014 Mar; 43(3):248-53. PubMed ID: 24389080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.
    Bayston R; Ullas G; Ashraf W
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2842-5. PubMed ID: 22430965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
    LaPlante KL; Mermel LA
    Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ; Cappelletty DM; Moldovan T; Aeschlimann JR; Kaatz GW
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.